Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients

Cytokine

Volumn 43, Issue 2, 2008, Pages 132-137

  Farhat, Karim ^a   Hassen, Elham ^a   Bouzgarrou, Nadia ^a   Gabbouj, Sallouha ^a   Bouaouina, Noureddine ^a,b   Chouchane, Lotfi ^a,c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Interleukin 18; Nasopharyngeal carcinoma; Susceptibility

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 18; TUMOR MARKER;

ADULT; ADVANCED CANCER; ALLELE; ARTICLE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NASOPHARYNX CARCINOMA; ONSET AGE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TUNISIA;

ADULT; DNA; FEMALE; GENOME, HUMAN; GENOTYPE; HEALTH; HUMANS; INTERLEUKIN-18; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUNISIA;

EID: 48049103897     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.05.004     Document Type: Article

References (47)

1. Ferlay J., Bray F., Pisani P., and Parkin D.M. Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0 [CD-ROM]. IARC CancerBase n°5 (2001), IARC Press, Lyon
2. Lombardi F., Gasparini M., Gianni C., De Marie M., Molinari R., and Pilotti S. Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol 10 (1982) 243-250
3. Khabir A., Sellami A., Sakka M., Ghorbel A.M., Daoud J., Frikha M., et al. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 6 (2000) 3932-3936
4. Berberoglu S., Ilhan I., Cetindag F., and Sunter O. Nasopharyngeal carcinoma in Turkish children: review of 33 cases. Pediatr Hematol Oncol 18 (2001) 309-315
5. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12 (2002) 431-441
6. Tang K.F., Chan S.H., Loh K.S., Chong S.M., Wang D., Yeoh K.H., et al. Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status. Cancer Lett 140 (1999) 93-98
7. Tang K.F., Tan S.Y., Chan S.H., Chong S.M., Loh K.S., Tan L.K., et al. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages. Hum Pathol 32 (2001) 42-49
8. Hu H., Tang K.F., Chua Y.N., Lu J., Feng P., Chew C.T., et al. Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration. Hum Pathol 35 (2004) 722-728
9. Okamura H., Kawaguchi K., Shoji K., and Kawade Y. High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun 38 (1982) 440-443
10. Hoshino T., Wiltrout R.H., and Young H.A. IL-18 is a potent conducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 162 (1999) 5070-5077
11. Gracie J.A., Robertson S.E., and McInnes I.B. Interleukin-18. J Leukoc Biol 73 (2003) 213-224
12. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 11 (2004) 405-410
13. Osaki T., Peron J.M., Cai Q., Okamura H., Robbins P.D., Kurimoto M., et al. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ and IL-12-independent antitumor effects. J Immunol 160 (1998) 1742-1749
14. Cao R., Farnebo J., Kurimoto M., and Cao Y. Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J 13 (1999) 2195-2202
15. Tatsumi T., Gambotto A., Robbins P.D., and Storkus W.J. Interleukin-18 gene transfer expends the repertoire of antitumor TH1-type immunity elicited by dendritic cell-based vaccines in association with enhanced therapeutic efficacy. Cancer Res 62 (2002) 5853-5858
16. Hartenbach E.M., Olson T.A., Goswitz J.J., Mohanraj D., Twiggs L.B., Carson L.F., et al. Vascular endothelial growth factor expression and survival in human epithelial ovarian carcinomas. Cancer Lett 121 (1997) 169-175
17. Vidal-Vanaclocha F., Mendoza L., Telleria N., Salado C., Valcarcel M., Gallot N., et al. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 25 (2006) 417-434
18. Giedraitis V., He B., Huang W.X., and Hillert J. Cloning and mutation analysis of IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112 (2001) 146-152
19. Higa S., Hirano T., Mayumi M., Hiraoka M., Ohshima Y., Nabu M., et al. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy 33 (2003) 1097-1102
20. Sugiura T., Kawaguchi Y., Harigai M., Terajima-Ichida H., Kitamura Y., Furuya T., et al. Association between adult-onset still's disease and interleukin-18 gene polymorphisms. Genes Immun 3 (2002) 394-399
21. Sivalingam S.P., Yoon K.H., Koh D.R., and Fong K.Y. Single nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 62 (2003) 498-504
22. Ben Abdallah M. Epidémiologie des cancers en Tunisie: registre de l'Institut Salah Azaiz (1994-1999). Tunis: Association tunisienne de lutte contre le cancer; 2004.
23. In: Sobin L.H., and Wittekind C. (Eds). UICC (International Union Against Cancer). TNM classification of malignant tumors. 5th ed. (1997), Wiley, New York, Chicehester, Weinheim, Brisbane, Singapore, Toronto
24. Oletup H., and Zetterquiest H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in two hours: an alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation. Tissue Antigens 39 (1992) 225-235
25. Folwaczny M., Glas J., TöröK H.P., Tonenchi L., Paschos E., Bauer B., et al. Polymorphisms of interleukin-18 gene in periodontits patients. J Clin Periodontol 32 (2005) 530-534
26. Novak N., Kruse S., Potreck J., Maintz L., Jenneck C., Weidinger S., et al. Single nucleotide polymorphisms of the IL-18 gene are associated with atopic eczema. J Allergy Clin Immunol 115 (2005) 828-833
27. Pratesi C., Bortolin M.T., Bidoli E., Tedeschi R., Vaccher E., Dolcetti R., et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55 (2006) 23-30
28. Heinzmann A., Gerhold K., Ganter K., Kurz T., Schuchmann L., Keitzer R., et al. Association study of polymorphisms within interleukin-18 in juvenile idiopathic arthritis and bronchial asthma. Allergy 59 (2004) 845-849
29. Hiromatsu Y., Mukai T., Kaku H., Miyake I., Ichimura M., Fukutani T., et al. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet Med 23 (2006) 211-215
30. Xu Q., Tin S.K., Paramalingam S.S., Thumboo J., Koh D.R., and Fong K.Y. Interleukin-18 promoter gene polymorphisms in Chinese patients with systemic lupus erythematosus: association with CC genotype at position -607. Ann Acad Med Singapore 36 (2007) 91-95
31. Wei Y.S., Lan Y., Liu Y.G., Tang H., Tang R.G., and Wang J.C. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 17 (2007) 1-7
32. Liu Y., Lin N., Huang L., Xu Q., and Pang G. Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer. DNA Cell Biol 26 (2007) 613-618
33. Nikiteas N., Yannopoulos A., Chatzitheofylaktou A., and Tsigris C. Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer. Anticancer Res 27 (2007) 3849-3853
34. Bushley A.W., Ferrell R., McDuffie K., Terada K.Y., Carney M.E., Thompson P.J., et al. Polymorphisms of interleukin (IL-1A, IL-1h, IL-6, IL-10 and IL-18 and the risk of ovarian cancer. Gynecol Oncol 95 (2004) 672-679
35. Vairaktaris E., Serefoglou Z.C., Yapijakis C., Agapi C., Vassiliou S., Nkenke E., et al. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer. Anticancer Res 27 6B (2007) 4011-4014
36. Barbulescu K., Becker C., Schlaak J.F., Schmitt E., Meyer zum Büschenfelde K.H., and Neurath M.F. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promoter in primary CD4+ T lymphocytes. J Immunol 160 (1998) 3642-3647
37. Dinarello C.A., Novick D., Puren A.J., Fantuzzi G., Shapiro L., Muhl H., et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 63 (1998) 658-664
38. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., et al. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158 (1997) 1541-1550
39. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 147 (1991) 3815-3822
40. Fujieda S., Lee K., Sunaga H., Tsuzuki H., Ikawa H., Fan G.K., et al. Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma. Cancer 85 (1999) 1439-1445
41. Chang C.Y., Lee J., Kim E.Y., Park H.J., Kwon C.H., Joh J.W., et al. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. BMC Cancer 7 (2007) 87
42. Nakamura Y., Yamada N., Ohyama H., Nakasho K., Nishizawa Y., Okamoto T., et al. Effect of interleukin-18 on metastasis of mouse osteosarcoma cells. Cancer Immunol Immunother 55 (2006) 1151-1158
43. Khabir A., Ghorbel A., Daoud J., Frikha M., Drira M.M., Laplanche A., et al. Similar BCL-X but different BCL-2 levels in the two age groups of North African nasopharyngeal carcinomas. Cancer Detect Prev 27 (2003) 250-255
44. Jalbout M., Bel Haj Jrad B., Bouaouina N., Gargouri J., Yacoub S., Zakhama A., et al. Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int J Cancer 10 (2002) 146-150
45. Hassen E., Farhat K., Gabbouj S., Jalbout M., Bouaouina N., and Chouchane L. TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. Cancer Genet Cytogenet 175 (2007) 41-46
46. Crawford D.H. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356 (2001) 461-473
47. Hoffmann S.C., Stanley E.M., Cox E.D., DiMercurio B.S., Koziol D.E., Harlan D.M., et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 6 (2002) 560-567